RAC 0.54% $1.83 race oncology ltd

Ann: Race Strategic Update August 2023, page-589

  1. 8,362 Posts.
    lightbulb Created with Sketch. 1379
    So you think that Amgen is relaxed about its Kyprolis patent expiry in 2025?

    Re loans, I've already suggested that LT should get the ball rolling by inviting Twiggy to join Le Raz.
 
watchlist Created with Sketch. Add RAC (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.